Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,366,000
-25,000 (-1.80%)
Sep 23, 2026, 3:30 PM KST
Samsung Biologics Employees
Samsung Biologics had 5,326 employees as of June 30, 2026. The number of employees increased by 279 or 5.53% compared to the same quarter last year.
Employees
5,326
Change (1Y)
279
Growth (1Y)
5.53%
Revenue / Employee
961.55M KRW
Profits / Employee
372.57M KRW
Market Cap
63.16T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 5,326 | 279 | 5.53% |
| Jun 30, 2025 | 5,047 | 303 | 6.39% |
| Dec 31, 2024 | 4,770 | 486 | 11.34% |
| Sep 30, 2024 | 4,744 | 460 | 10.74% |
| Sep 30, 2023 | 4,284 | - | - |
| Mar 31, 2023 | 4,296 | - | - |
| Mar 31, 2021 | 3,247 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Samsung Biologics News
- 23 days ago - Samsung Biologics Publishes PolyPeptide Offer Prospectus; Sets Tender Period - Nasdaq
- 26 days ago - Samsung Biologics Plans $2 Billion Fundraising for PolyPeptide Acquisition - GuruFocus
- 26 days ago - Samsung Biologics Plans $21.7 Billion Fundraising for Growth Strategy - GuruFocus
- 2 months ago - Samsung Biologics Slides: Q2 2026 - Filings
- 2 months ago - Samsung Biologics Quarterly report: Q2 2026 - Filings
- 2 months ago - Samsung Biologics Delivers Solid Q2 2026 Growth, Operating Profit Rises - Nasdaq
- 2 months ago - Samsung Biologics (005940) Proposes $1.8 Billion Acquisition of Polypeptide Group - GuruFocus
- 2 months ago - Samsung Biologics to Acquire Peptide Group for $1.8 Billion (SMCI) - GuruFocus